Search results
Results from the WOW.Com Content Network
Neurology. Chemotherapy-induced peripheral neuropathy (CIPN) is a nerve -damaging side effect of antineoplastic agents in the common cancer treatment, chemotherapy. [1] CIPN afflicts between 30% and 40% of patients undergoing chemotherapy. Antineoplastic agents in chemotherapy are designed to eliminate rapidly dividing cancer cells, but they ...
Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent cancer recurrence. ... (numbness or tingling in hands, arms, feet, legs)
Dermatology. Chemotherapy-induced acral erythema, also known as palmar-plantar erythrodysesthesia or hand-foot syndrome is reddening, swelling, numbness and desquamation (skin sloughing or peeling) on palms of the hands and soles of the feet (and, occasionally, on the knees, elbows, and elsewhere) that can occur after chemotherapy in patients ...
Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (), compression (compression neuropathy), chemotherapy (chemotherapy-induced peripheral neuropathy).
Then she learned she had ovarian cancer at 20. Meghan Holohan. August 14, 2024 at 6:50 PM. Molly Smith experienced pins and needles in her hands and feet, which eventually led to the discovery of ...
Chemotherapy-induced peripheral neuropathy is a progressive, enduring and often irreversible tingling numbness, intense pain, and hypersensitivity to cold, beginning in the hands and feet and sometimes involving the arms and legs caused by some chemotherapy agents. [7]
To treat tingling in the fingers, “first and foremost, you have to come up with the correct diagnosis,” says Dr. Hisham Awan, an orthopedic surgeon and director of the Hand and Upper Extremity ...
Post-chemotherapy cognitive impairment (PCCI) (also known in the scientific community as " CRCIs or Chemotherapy-Related Cognitive Impairments " and in lay terms as chemotherapy-induced cognitive dysfunction or impairment, chemo brain, or chemo fog) describes the cognitive impairment that can result from chemotherapy treatment.